Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Kohei, Sawada"'
Autor:
Jun‐ichi Okada, Takashi Yoshinaga, Takumi Washio, Kohei Sawada, Seiryo Sugiura, Toshiaki Hisada
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 1092-1100 (2021)
Abstract The risk of fatal arrhythmias is the major concern for using chloroquine (CQ) or hydroxychloroquine (HCQ) to treat coronavirus disease 2019 (COVID‐19), but the reported number of life‐threatening arrhythmic events or deaths is relatively
Externí odkaz:
https://doaj.org/article/39cb3bdd46eb44579a0359d4cbb46fbb
Publikováno v:
Journal of Pharmacological Sciences, Vol 140, Iss 4, Pp 313-316 (2019)
Using bright-field images of cultured human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), we trained a convolutional neural network (CNN), a machine learning technique, to decide whether the qualities of cell cultures are suitable
Externí odkaz:
https://doaj.org/article/e2fd8fc0d9df4d60b03636c461892bab
Publikováno v:
Journal of Pharmacological Sciences, Vol 138, Iss 4, Pp 233-239 (2018)
Cardiac safety assessment is challenging because a better understanding of torsadogenic mechanisms beyond hERG blockade and QT interval prolongation is necessary for patient safety. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM
Externí odkaz:
https://doaj.org/article/f8bba6ec3dca42b591e093427eda3612
Autor:
Ksenia Blinova, Qianyu Dang, Daniel Millard, Godfrey Smith, Jennifer Pierson, Liang Guo, Mathew Brock, Hua Rong Lu, Udo Kraushaar, Haoyu Zeng, Hong Shi, Xiaoyu Zhang, Kohei Sawada, Tomoharu Osada, Yasunari Kanda, Yuko Sekino, Li Pang, Tromondae K. Feaster, Ralf Kettenhofen, Norman Stockbridge, David G. Strauss, Gary Gintant
Publikováno v:
Cell Reports, Vol 24, Iss 13, Pp 3582-3592 (2018)
Summary: To assess the utility of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as an in vitro proarrhythmia model, we evaluated the concentration dependence and sources of variability of electrophysiologic responses to 28 dr
Externí odkaz:
https://doaj.org/article/3766b15437f1454ca223759395ad3b34
Autor:
Kohei Sawada, Norimasa Miyamoto, Masao Iwata, Kotaro Kodama, Yukinori Minoshima, Kazuma Takase, Megumi Ikemori Kawada, Kiyoshi Okamoto, Yusuke Narita
PDF - 86K, Cleavaged -PARP induction in A375 and G361 parental cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40fda413fcc7696489812e084a3521dc
https://doi.org/10.1158/1535-7163.22500801
https://doi.org/10.1158/1535-7163.22500801
Autor:
Kohei Sawada, Norimasa Miyamoto, Masao Iwata, Kotaro Kodama, Yukinori Minoshima, Kazuma Takase, Megumi Ikemori Kawada, Kiyoshi Okamoto, Yusuke Narita
PDF - 83K, Effect of vemurafenib, selumetinib, or E6201 on Cyclin D1 expression in exogenous MEK1-WT-positive or -negative A375 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a474bc8cb4b1e9fe9f11006ed75633c0
https://doi.org/10.1158/1535-7163.22500810.v1
https://doi.org/10.1158/1535-7163.22500810.v1
Autor:
Kohei Sawada, Norimasa Miyamoto, Masao Iwata, Kotaro Kodama, Yukinori Minoshima, Kazuma Takase, Megumi Ikemori Kawada, Kiyoshi Okamoto, Yusuke Narita
PDF - 68K, Effect of vemurafenib, selumetinib, or E6201 on Cyclin D1 expression in (A) exogenous MEK1-C121S-positive or -negative G361 cells and in (B) exogenous MEK1-WT-positive or -negative G361 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12305ed39ad8fa57e460db11a2b6c30d
https://doi.org/10.1158/1535-7163.22500804
https://doi.org/10.1158/1535-7163.22500804
Autor:
Kohei Sawada, Norimasa Miyamoto, Masao Iwata, Kotaro Kodama, Yukinori Minoshima, Kazuma Takase, Megumi Ikemori Kawada, Kiyoshi Okamoto, Yusuke Narita
PDF - 50K, Legends for Supplementary Figures 1 through 4.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f6b4377c08e78c7fc45578cf968899a
https://doi.org/10.1158/1535-7163.22500798.v1
https://doi.org/10.1158/1535-7163.22500798.v1
Autor:
Kohei Sawada, Norimasa Miyamoto, Masao Iwata, Kotaro Kodama, Yukinori Minoshima, Kazuma Takase, Megumi Ikemori Kawada, Kiyoshi Okamoto, Yusuke Narita
Many clinical cases of acquired resistance to the BRAF inhibitor vemurafenib have recently been reported. One of the causes of this acquired resistance is the BRAF downstream kinase point mutation MEK1-C121S. This mutation confers resistance to not o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d10963634a99d6314e7ae3989d78d186
https://doi.org/10.1158/1535-7163.c.6536577.v1
https://doi.org/10.1158/1535-7163.c.6536577.v1
Autor:
Kohei Sawada, Norimasa Miyamoto, Masao Iwata, Kotaro Kodama, Yukinori Minoshima, Kazuma Takase, Megumi Ikemori Kawada, Kiyoshi Okamoto, Yusuke Narita
PDF - 164K, MAPK pathway inhibitory activity of the test compounds in G361.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b21214ed70527339d1143dfcb4e465b
https://doi.org/10.1158/1535-7163.22500807
https://doi.org/10.1158/1535-7163.22500807